Hyperpolarized Carbon-13 (13C) Pyruvate Imaging in Patients With Glioblastoma

Clinical trial NCT04019002 · COMPLETED

Trial details

NCT number: NCT04019002
Sponsor: Susan Chang
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Glioblastoma Multiforme (GBM)

Start date: 2019-11-19
Primary completion: 2025-09-30
Enrollment: 17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.